Picard Medical, Inc. Common Stock (PMI)
R&D Expense Growth
-27.49%
Quarterly · Period ending:
PMI R&D Expense Growth
Latest reported-27.49%period ending
Latest reported-27.49%period ending
PMI Quarterly R&D Growth (QoQ) (0.00% → -27.49%)
Latest values, visible window
High-resolution chart · PNG
PMI r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -27.4934% | |
| 280.5221% | |
| -47.6341% | |
| 27.9946% | |
| -8.0446% | |
| 2.4081% | |
| -17.898% | |
| 2.234% | |
| 36.2319% | |
| 18.9655% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |